Abbott sues DexCom over glucose-monitoring patent settlement, license [Reuters]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Reuters
Abbott says DexCom breached settlement agreement, patent license The company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we continue to test and develop in beta. We welcome feedback, which you can provide using the feedback tab on the right of the page. (Reuters) - An Abbott Laboratories subsidiary focused on diabetes care sued rival DexCom in Delaware federal court for allegedly violating a 2014 settlement agreement and asked the court to declare that Abbott doesn't infringe its patents. The lawsuit filed Wednesday is sealed, and the motion to seal says it relates to Abbott's Freestyle Libre continuous glucose monitoring system. Chicago-based Abbott made more than $2.6 billion from worldwide sales of Freestyle Libre products last year, according to a filing with the U.S. Securities and Exchange Commission. DexCom's flagship G6 system is a rival to the Freestyle Libre. The settlement gave the
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- DexCom (DXCM) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]Yahoo! Finance
- Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection [Yahoo! Finance]Yahoo! Finance
- Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy [Yahoo! Finance]Yahoo! Finance
- IDTechEx Examines the Opportunities for Wearables in Digital Health [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/8/24 - Beat
DXCM
Sec Filings
- 4/23/24 - Form 144
- 4/22/24 - Form ARS
- 4/22/24 - Form DEF
- DXCM's page on the SEC website